Pieternella Lugtenburg

31PUBLICATIONS
145CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedAnimal physiology - cell
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Feb 14, 2026
A Lesion-adaptive Segmentation Approach for Tumor Delineation on FDG PET/CT in Diffuse Large B-cell Lymphoma Patients.

Gerben J C Zwezerijnen, Martijn W Heymans, Danielle van Assema

|Sep 08, 2025
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma.

Lorenzo Falchi, Anna Sureda, Sirpa Leppä

|Aug 18, 2025
Can we obtain prognostic information from healthy tissue uptake and volume in baseline 18F-FDG PET/CT imaging in diffuse large B-cell lymphoma?

Nienke R Gerards, Sanne E Wiegers, Anne L Bes

|Jan 10, 2025
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.

Joshua D Brody, Judit Jørgensen, David Belada

|Feb 15, 2024
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.

Suzanne I M Neppelenbroek, Yvonne M Geurts, Berthe M P Aleman

|Sep 09, 2023
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.

Anne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers

Pageof 6

Frequent Collaborators

12 joint publications

Josee M Zijlstra

10 joint publications

Jakoba J Eertink

10 joint publications

Sanne E Wiegers

9 joint publications

Gerben J C Zwezerijnen